Contract 75D30119D04513
Pfizer Inc · Department Of Health And Human Services · March 28, 2019
Pfizer Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 28, 2019 for $995.46 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 31, 2023.
Contract details
- PIID
- 75D30119D04513
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 28, 2019
- Latest action
- August 31, 2023
Description
2019 VACCINES FOR CHILDREN
Modification timeline
-
August 31, 2023Mod P00006$0
-
June 30, 2020Mod P00005$-3.2K
-
January 17, 2020Mod P00004$110.90M
-
October 22, 2019Mod P00003$297.25M
-
August 9, 2019Mod P00002$142.78M
-
June 18, 2019Mod P00001$139.27M
-
March 28, 2019Base award$305.25M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30119D04513?
Contract 75D30119D04513 is a federal contract awarded to Pfizer Inc by Department Of Health And Human Services on March 28, 2019 for $995.46 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract 75D30119D04513?
Pfizer Inc won contract 75D30119D04513 from Department Of Health And Human Services.
How much is contract 75D30119D04513 worth?
Contract 75D30119D04513 has obligated $995.46 million to date, with a total potential value of $1.45 billion if all options are exercised.